Global Corticosteroids Market Size study & Forecast, by Product (Glucocorticoids, Mineralocorticoids), Route of Administration (Topical Steroids, Inhaled Steroids, Oral Forms, Systemic Forms, Others), Application (Rheumatology Indications, Skin Allergies,

Global Corticosteroids Market Size study & Forecast, by Product (Glucocorticoids, Mineralocorticoids), Route of Administration (Topical Steroids, Inhaled Steroids, Oral Forms, Systemic Forms, Others), Application (Rheumatology Indications, Skin Allergies, Endocrinology, Gastroenterology, Acute Respiratory Diseases, Others) and Regional Analysis, 2022-2029

Global Corticosteroids Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Corticosteroids are a group of steroidal hormones that are generated in the adrenal cortex and are used to treat a variety of diseases, including kidney disease, autoimmune illness, GIT disease, skin disease, cerebral edema, and others. These steroids are also used in replacement treatment and organ transplantation. The Corticosteroids market is expanding because of factors such increase in the prevalence of chronic & infectious diseases and a rise in therapeutical product application. Continuing R&D in the pharmaceutical sector is predicted to open up new market possibilities throughout the forecast period.

According to the United Nations report 2020, the anticipated human population would rise from 7.2 billion now to 8.2 billion by 2025. By the end of 2020, this causes the worldwide burden of chronic illnesses to increase to 57%. About 25 million Americans have asthma, according to the Centers for Disease Control and Prevention's 2020 report. This equates to around 1 in 13 Americans, which includes 8% of adults and 7% of children. Asthma affects over 20 million American individuals who are 18 years of age and older. However, risk factors associated with Corticosteroids on Prolonged use stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Corticosteroids Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the increasing incidence of lifestyle-related diseases and developed economy, increasing health care expenditure. However, Asia Pacific is expected to be the fastest growing region due to the high adoption of technologically advanced products.

Major market players included in this report are:
Johnson & Johnson Services, Inc.
Pfizer Inc.
Sumitomo Corporation
GlaxoSmithKline plc
Novartis AG
Bayer AG Pharmaceutical
Sanofi S.A.
AstraZeneca plc
Merck & Co., Inc.
Cipla Inc.

Recent Developments in the Market:
 The first participant in a pilot trial testing vamorolone as a possible therapy for Becker Muscular Dystrophy (BMD) received the first dosage in August 2022. As a potential treatment for various forms of muscular dystrophy, ReveraGen BioPharma has been researching and developing the steroid treatment.
 In April 2022, Global pharmaceutical business Eli Lilly and Company announced that the third pivotal Phase 3 trial using Lebrikizumab, an IL-13 inhibitor, in combination with Tropical Corticosteroids (TCS), significantly reduced disease severity in patients with moderate-to-severe Atopic Dermatitis (AD) (ADhere).

Global Corticosteroids Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Route of Administration, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Product:
Glucocorticoids
Mineralocorticoids
By Route of Administration:
Topical steroids
Inhaled steroids
Oral forms
Systemic forms
Others
By Application:
Rheumatology indications
Skin allergies
Endocrinology
Gastroenterology
Acute respiratory diseases
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

Johnson & Johnson Services, Inc.
Pfizer Inc.
Sumitomo Corporation
GlaxoSmithKline plc
Novartis AG
Bayer AG Pharmaceutical
Sanofi S.A.
AstraZeneca plc
Merck & Co., Inc.
Cipla Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.